Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study
- PMID: 36631851
- PMCID: PMC9835379
- DOI: 10.1186/s12893-022-01892-6
Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study
Abstract
Background: We investigated the usefulness of apparent diffusion coefficients (ADC) from diffusion-weighted images (DWI) obtained using magnetic resonance imaging (MRI) for prognosis of early hepatocellular carcinoma (HCC): Barcelona Clinic Liver Cancer (BCLC) stage 0 and A.
Methods: We enrolled 102 patients who had undergone surgical resection for early HCC: BCLC stage 0 and A, and calculated their minimum ADC using DWI-MRI. We divided patients into ADCHigh (n = 72) and ADCLow (n = 30) groups, and compared clinicopathological factors between the two groups.
Results: The ADCLow group showed higher protein induced by vitamin K absence-II (PIVKA-II) levels (p = 0.02) compared with the ADCHigh group. In overall survival, the ADCLow group showed significantly worse prognosis than the ADCHigh group (p < 0.01). Univariate analysis identified multiple tumors, infiltrative growth, high PIVKA-II, and low ADC value as prognostic factors. Multivariate analysis identified infiltrative growth and low ADC value as an independent prognostic factor.
Conclusion: ADC values can be used to estimate the prognosis of early HCC.
Keywords: Apparent diffusion coefficient; Hepatocellular carcinoma; Magnetic resonance imaging; Prognostic prediction.
© 2023. The Author(s).
Conflict of interest statement
M.S. received research grants from TAIHO PHARMACEUTICAL CO., LTD., TSUMURA & CO. Other authors have no competing interest related to this study.
Figures






Similar articles
-
Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.Cancer Biother Radiopharm. 2018 Sep;33(7):300-306. doi: 10.1089/cbr.2018.2483. Epub 2018 Aug 15. Cancer Biother Radiopharm. 2018. PMID: 30109954
-
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.Abdom Radiol (NY). 2019 Aug;44(8):2740-2750. doi: 10.1007/s00261-019-02030-2. Abdom Radiol (NY). 2019. PMID: 31069479
-
Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.J Magn Reson Imaging. 2019 Apr;49(4):975-983. doi: 10.1002/jmri.26253. Epub 2018 Sep 12. J Magn Reson Imaging. 2019. PMID: 30277628
-
Beyond the vascular profile: conventional DWI, IVIM and kurtosis in the assessment of hepatocellular carcinoma.Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7284-7293. doi: 10.26355/eurrev_202007_21883. Eur Rev Med Pharmacol Sci. 2020. PMID: 32706066 Review.
-
Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?Cancer J. 2023 Jul-Aug 01;29(4):238-242. doi: 10.1097/PPO.0000000000000668. Cancer J. 2023. PMID: 37471615 Free PMC article. Review.
Cited by
-
Preoperative prediction of early recurrence in hepatocellular carcinoma using simultaneous multislice diffusion kurtosis imaging.Eur Radiol. 2025 May 6. doi: 10.1007/s00330-025-11633-x. Online ahead of print. Eur Radiol. 2025. PMID: 40328957
-
Prognostic and predictive imaging markers of hepatocellular carcinoma: a pictorial essay.Insights Imaging. 2025 Aug 15;16(1):181. doi: 10.1186/s13244-025-02058-7. Insights Imaging. 2025. PMID: 40815430 Free PMC article.
-
The relationship between the tumor microenvironment of hepatocellular carcinoma - including cancer-associated fibroblasts and tumor-associated macrophages - and apparent diffusion coefficient.Am J Cancer Res. 2025 Apr 15;15(4):1747-1758. doi: 10.62347/ZGGJ9531. eCollection 2025. Am J Cancer Res. 2025. PMID: 40371143 Free PMC article.
-
Distinguishing Hepatocellular Carcinoma from Cirrhotic Regenerative Nodules Using MR Cytometry.Cancers (Basel). 2025 Apr 1;17(7):1204. doi: 10.3390/cancers17071204. Cancers (Basel). 2025. PMID: 40227785 Free PMC article.
References
-
- Clinical practice guidelines for hepatocellular carcinoma. The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical